Shaolin Capital Management’s Aimei Health Technology Right AFJKR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$9.14K Buy
105,000
+4,169
+4% +$511 ﹤0.01% 599
2026
Q2
$23.2K Buy
100,831
+831
+0.8% +$232 ﹤0.01% 537
2026
Q1
$30.8K Sell
100,000
-50,000
-33% -$18.6K ﹤0.01% 461
2025
Q4
$56.1K Sell
150,000
-49,220
-25% -$18.6K ﹤0.01% 355
2025
Q3
$63.8K Hold
199,220
– – ﹤0.01% 281
2025
Q2
$47.8K Sell
199,220
-600
-0.3% -$153 ﹤0.01% 233
2025
Q1
$71.9K Sell
199,820
-65,180
-25% -$16.7K ﹤0.01% 125
2024
Q4
$47.7K Buy
265,000
+11,900
+5% +$2.59K ﹤0.01% 138
2024
Q3
$58.2K Buy
253,100
+53,100
+27% +$13.1K ﹤0.01% 121
2024
Q2
$42K Sell
200,000
-50,000
-20% -$11.2K ﹤0.01% 179
2024
Q1
$50K Buy
+250,000
New +$49.4K ﹤0.01% 170

Other funds holding AFJKR

Shaolin Capital Management's AFJKR Position: Q3 2026 in Review

Shaolin Capital Management increased its Aimei Health Technology Right (AFJKR) stake by 4.1% in Q3 2026, buying an estimated $511 and bringing the position to 105,000 shares worth $9.14K. The position accounts for ﹤0.01% of the portfolio, ranked #599.

Shaolin Capital Management first reported a position in AFJKR in Q1 2024 and has held it in 11 quarters since. The position peaked at $71.9K in Q1 2025. 15 funds tracked by Wall St. Rank hold AFJKR as of Q3 2026.

  • Shaolin Capital Management held 105,000 shares of Aimei Health Technology Right worth $9.14K as of Q3 2026.
  • Shaolin Capital Management bought 4,169 Aimei Health Technology Right shares in Q3 2026, an estimated $511.
  • Aimei Health Technology Right made up ﹤0.01% of Shaolin Capital Management's portfolio in Q3 2026, its #599 holding.
  • Shaolin Capital Management first reported a position in Aimei Health Technology Right in Q1 2024 and has held it in 11 quarters since.
  • Shaolin Capital Management's Aimei Health Technology Right position peaked at $71.9K in Q1 2025.
  • 15 funds tracked by Wall St. Rank held Aimei Health Technology Right as of Q3 2026.

Based on Shaolin Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.